Uurimisrühmad - Stabilis 4.0

Viimane versioon :
28/04/2024

Uurimisrühmad - Elan Pharmaceuticals Inc

Pdf

Ameerika ühendriigid

Farmaatsialaboratoorium

Elan Pharmaceuticals Inc

San Francisco

Email

Viited

Viited

(6)

1

Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration.
Shields DE, Aclan J, Szatkowski A. ()
Int J Pharm Compound - 2008 - ; 12, 5: 463-466.

2

Chemical stability of admixtures containing ziconotide 25 mcg/ml and morphine sulfate 10 mg/ml or 20 mg/ml during simulated intrathecal administration.
Shields D.E, Aclan J, Szatkowski A. ()
Int J Pharm Compound - 2008 - ; 12, 6: 553-557.

3

Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration.
Shields D, Montenegro R. ()
Neuromodulation - 2007 - ; 10, 1: 6-11.

4

Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration.
Shields D, Montenegro R, Aclan J. ()
Neuromodulation - 2007 - ; 10, 1: 12-17.

5

Chemical stability of admixture combining ziconotide and bupivacaine during simulated intrathecal administration.
Shields D, Montenegro R, Aclan J. ()
Neuromodulation - 2007 - ; 10, 1: 1-5.

6

Chemical stability of admixtures combining ziconotide with morphine or hydromorphone during simulated intrathecal administration.
Shields D, Montenegro R, Ragusa M. ()
Neuromodulation - 2005 - ; 8, 4: 257-263.

Ingredientide nimekiri

Molekulid uuritud

(8)

		Baclofen
		Bupivacaine hydrochloride
		Clonidine hydrochloride
		Fentanyl citrate
		Hydromorphone hydrochloride
		Morphine sulfate
		Sufentanil citrate
		Ziconotide acetate

Mentions Légales